Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery

Abstract— The recently described hemoglobin scavenger receptor CD163 mediates the endocytosis of hemoglobin:haptoglobin (Hb:Hp) complexes and thereby counters Hb-induced oxidative tissue damage after hemolysis. Although CD163 has been indirectly associated with antiinflammatory and atheroprotective activity, no ligand-receptor-effector pathway has yet been described for this receptor. To understand the significance of CD163 and more clearly define downstream pathways linked to inflammatory resolution, we studied the expression and function of CD163 in human monocytes/macrophages using both in vitro and in vivo models. Differentiation of human blood monocytes into macrophages either by in vitro culture or in resolving cantharidin-induced skin blisters led to an equivalent increase (>15×) in CD163 expression. Elevated CD163 levels were also noted on circulating monocytes in cardiac surgical patients during the resolution phase of the systemic inflammatory response to cardiopulmonary bypass surgery. In each case, binding of Hb:Hp to CD163-bearing cells elicited potent interleukin-10 secretion, and this was inhibited by the anti-CD163 antibody RM3/1. Release of interleukin-10, in turn, induced heme oxygenase-1 stress protein synthesis via an autocrine mechanism. Such induction of heme oxygenase-1 was observed in vivo 24 to 48 hours after the onset of cardiopulmonary bypass surgery. These results identify novel antiinflammatory and cytoprotective effector pathways in human monocytes/macrophages related to Hb scavenging and metabolism, which may have relevance in atheroprotection, wound healing, and patient recovery postoperatively.

[1]  V. Skinner,et al.  The state of macrophage differentiation determines the TNF alpha response to nitrated lipoprotein uptake. , 2003, Atherosclerosis.

[2]  C. Figdor,et al.  The heme-heme oxygenase system: a molecular switch in wound healing. , 2003, Blood.

[3]  A. Levy,et al.  Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.

[4]  N. Bodyak,et al.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury , 2003, Nature Medicine.

[5]  K. Jablonski,et al.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. , 2002, Journal of the American College of Cardiology.

[6]  O. Florey,et al.  Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. , 2002, Arthritis and rheumatism.

[7]  Tzong-Shyuan Lee,et al.  Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice , 2002, Nature Medicine.

[8]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  A. Levy,et al.  Structure-function analysis of the antioxidant properties of haptoglobin. , 2001, Blood.

[10]  F. Bach,et al.  Heme oxygenase‐1, a protective gene that prevents the rejection of transplanted organs , 2001, Immunological reviews.

[11]  J. Lebreton,et al.  Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. , 2001, American journal of respiratory and critical care medicine.

[12]  P. Högger,et al.  Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. , 2001, Biochemical and biophysical research communications.

[13]  A. Forbes,et al.  Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. , 2001, Journal of immunological methods.

[14]  E. Hurt-Camejo,et al.  Intravascular hemolysis increases atherogenicity of diet-induced hypercholesterolemia in rabbits in spite of heme oxygenase-1 gene and protein induction. , 2001, Atherosclerosis.

[15]  G. Wright.  Haemolysis during cardiopulmonary bypass: update , 2001, Perfusion.

[16]  S. Kennedy,et al.  Immunocytochemical detection of Fcγ receptors in human atherosclerotic lesions , 2001 .

[17]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[18]  A. Choi,et al.  Heme oxygenase: colors of defense against cellular stress. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[19]  P. Wallace,et al.  Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. , 2000, Cytokine.

[20]  M. Aoki,et al.  Free hemoglobin impairs cardiac function in neonatal rabbit hearts. , 2000, The Annals of thoracic surgery.

[21]  D. Haskard,et al.  Leukocyte integrin expression in patients undergoing cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.

[22]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[23]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[24]  R. Beelen,et al.  Regulation of CD163 on human macrophages: cross‐linking of CD163 induces signaling and activation , 1999, Journal of leukocyte biology.

[25]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[26]  F. Costantini,et al.  Increased susceptibility in Hp knockout mice during acute hemolysis. , 1998, Blood.

[27]  S. Tonegawa,et al.  Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Taylor,et al.  SIRS--the systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.

[29]  J. Vincent,et al.  Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. , 1996, The Journal of thoracic and cardiovascular surgery.

[30]  W. Hamann,et al.  Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes , 1995, Inflammation Research.

[31]  W. Mcbride,et al.  Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. , 1995, British journal of anaesthesia.

[32]  A. Choi,et al.  Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.

[33]  D. Mason,et al.  A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily , 1993, European journal of immunology.

[34]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[35]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[36]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[37]  E. Berg,et al.  Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. , 1989, Science.

[38]  J. Eaton,et al.  Hemoglobin. A biologic fenton reagent. , 1984, The Journal of biological chemistry.

[39]  S. Moestrup,et al.  Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. , 2002, Blood.

[40]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[41]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.

[42]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[43]  D. Willis,et al.  Heme oxygenase: A novel target for the modulation of inflammatory response , 1996, Nature Medicine.

[44]  R. Voegeli,et al.  A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. , 1987, Experimental cell biology.